Ophthalmic emulsions containing prostaglandins
US8273362B2 · kind B2 · utility
21Cited by
12References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 10, 2005 |
| Grant date | Sep 25, 2012 |
| Priority date | — |
| Expiry date | Jan 27, 2026 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Cationic ophthalmic oil-in-water type emulsions, include colloid particles having an oily core surrounded by an interfacial film, the emulsion including at least one cationic agent and at least one non ionic surfactant, the oily core including a prostaglandin selected from the group comprising in particular latanoprost, unoprostone isopropyl, travoprost, bimatoprost, tafluprost, 8-isoprostaglandinE2, or a mixture thereof, for treating ocular hypertension and/or glaucoma. These emulsions have the property to increase the chemical stability of prostaglandins.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.